The FDA, amid growing concerns about the risk of uncontrolled bleeding when taking Pradaxa, has determined that an additional comprehensive study of the drug is necessary to determine its safety in comparison with warfarin. See FDA’s statement at the following.
Pradaxa to undergo new FDA safety study
